COVID-19 and Commercial Teams: What We’ve Learned So Far (Part 3)
In this blog series, Aktana is sharing some of the less […]
COVID-19 and Commercial Teams: What We’ve Learned So Far (Part 2)
In this blog series, Aktana is sharing some of the less […]
COVID-19 and Commercial Teams: What We’ve Learned So Far (Part 1)
The novel coronavirus and resulting disease, COVID-19, […]
Aktana Case Study: Being Agile During the COVID-19 Pandemic
The novel coronavirus, now termed COVID-19, appeared on […]
Keeping Up with AI: 6 Trends Transforming Commercial Life Sciences in 2020
As a new decade begins, we’re on the cusp of a full-scale transformation in life sciences. As mentioned in Gartner’s recent report, Predicts 2020: Life Science CIOs Must Digitalize for Business Growth, “AI (artificial intelligence) is one of the most powerful, transformational technologies to enable new business models, customer experiences, service offerings, and business ecosystems across multiple industries.” That transformation is underway in the way life sciences companies manage their commercial operations.
Bayer and Aktana at VECMS: Creating the Customer-Centered Commercial Model with Intelligent Engagement
This year’s European Veeva Commercial and Medical Summi […]
Compensating the AI-Directed Sales Force
It’s a topic that will only become more pressing as art […]
AI is a Must-Have for Life Sciences Commercial Teams: Aktana CEO David Ehrlich Interviewed on The Bio Report
Applying machine learning and artificial intelligence ( […]
Intelligent Engagement in the LatAm Market: Q&A with Eduardo Alonso, Aktana Head of Customer Success
The Veeva Commercial Summit in Sao Paulo is right aroun […]
Novartis and Aktana at Veeva Summit: Building the AI-Driven Commercial Engagement Model
We returned as a platinum sponsor once again to the Vee […]